Books on the topic 'Cardiovascular disease'

To see the other types of publications on this topic, follow the link: Cardiovascular disease.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Cardiovascular disease.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Cardiovascular disease. Ibadan: Spectrum Books, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gallo, Linda L., ed. Cardiovascular Disease. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5296-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wang, Qing K., ed. Cardiovascular Disease. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-159-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lorimer, A. Ross, and W. Stewart Hillis. Cardiovascular Disease. London: Springer London, 1986. http://dx.doi.org/10.1007/978-1-4471-3120-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Akinkugbe, O. O. Cardiovascular disease. Oxford: Blackwell Scientific, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Akinkugbe, O. O. Cardiovascular disease. Ibadan: Spectrum Books, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

1943-, Hillis W. Stewart, ed. Cardiovascular disease. Berlin: Springer-Verlag, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cardiovascular disease. New York, N.Y: Facts on File, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wood, David. Cardiovascular disease prevention. London: Mosby, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gallo, Linda L., ed. Cardiovascular Disease 2. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1959-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Geraldine, O'Gara, and Medical Education Partnership, eds. Diabetes & cardiovascular disease. London: Medical Education Partnership, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Administration, Florida Agency for Health Care. Women and cardiovascular disease: Cardiovascular hospitalizations. Tallahassee, Fla: AHCA, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Andrew, Steptoe, Rosengren Annika, and SpringerLink (Online service), eds. Stress and Cardiovascular Disease. London: Springer-Verlag London Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Peplow, Philip, James Adams, and Tim Young, eds. Cardiovascular and Metabolic Disease. Cambridge: Royal Society of Chemistry, 2015. http://dx.doi.org/10.1039/9781782622390.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Johnstone, Michael T., and Aristidis Veves. Diabetes and Cardiovascular Disease. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592590918.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Johnstone, Michael T., and Aristidis Veves, eds. Diabetes and Cardiovascular Disease. Totowa, NJ: Humana Press, 2005. http://dx.doi.org/10.1385/1592599087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Cicero, Arrigo F. G., and Manfredi Rizzo, eds. Nutraceuticals and Cardiovascular Disease. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-62632-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Barbaro, Giuseppe, and Franck Boccara, eds. Cardiovascular Disease in AIDS. Milano: Springer Milan, 2009. http://dx.doi.org/10.1007/978-88-470-0761-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Paneni, Francesco, and Francesco Cosentino. Diabetes and Cardiovascular Disease. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-17762-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Dhalla, Naranjan S., Heinz Rupp, Aubie Angel, and Grant N. Pierce, eds. Pathophysiology of Cardiovascular Disease. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4615-0453-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Andreadis, Emmanuel A., ed. Hypertension and Cardiovascular Disease. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39599-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Yusuf, Syed Wamique, and Jose Banchs, eds. Cancer and Cardiovascular Disease. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62088-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Nagano, Makoto, Seibu Mochizuki, and Naranjan S. Dhalla, eds. Cardiovascular Disease in Diabetes. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3512-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Bourassa, Martial G., and Jean-Claude Tardif, eds. Antioxidants and Cardiovascular Disease. Boston, MA: Springer US, 2006. http://dx.doi.org/10.1007/0-387-29553-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Hjemdahl, Paul, Andrew Steptoe, and Annika Rosengren, eds. Stress and Cardiovascular Disease. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84882-419-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Descovich, Giancarlo, Antonio Gaddi, Gianluigi Magri, and Sergio Lenzi, eds. Atherosclerosis and Cardiovascular Disease. Dordrecht: Springer Netherlands, 1990. http://dx.doi.org/10.1007/978-94-009-0731-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Tardif, Jean-Claude, and Martial G. Bourassa, eds. Antioxidants and Cardiovascular Disease. Dordrecht: Springer Netherlands, 2000. http://dx.doi.org/10.1007/978-94-011-4375-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Angel, Aubie, Naranjan Dhalla, Grant Pierce, and Pawan Singal, eds. Diabetes and Cardiovascular Disease. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1321-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Nishikimi, Toshio, ed. Adrenomedullin in Cardiovascular Disease. Boston, MA: Springer US, 2005. http://dx.doi.org/10.1007/b107323.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Freeman, Lita A., ed. Lipoproteins and Cardiovascular Disease. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-60327-369-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Barbaro, Giuseppe, and Franck Boccara, eds. Cardiovascular Disease in AIDS. Milano: Springer Milan, 2005. http://dx.doi.org/10.1007/b138963.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Patel, Vinood B., and Victor R. Preedy, eds. Biomarkers in Cardiovascular Disease. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-007-7741-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Anthony, Ware J., and Simons Michael, eds. Angiogenesis and cardiovascular disease. New York: Oxford University Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

K, Robinson Malcolm, and Thomas Abraham 1965-, eds. Obesity and cardiovascular disease. New York: Taylor & Francis, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

G, Julian Desmond, ed. Thrombolysis in cardiovascular disease. New York: M. Dekker, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

McQuarrie, Emily P., Hallvard Holdaas, Bengt Fellström, and Alan G. Jardine. Cardiovascular disease. Edited by Jeremy R. Chapman. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0285.

Full text
Abstract:
Premature cardiovascular disease is much more common in renal transplant recipients than the general population, although less common than in patients relying on maintenance haemodialysis. Cardiovascular disease in renal transplant recipients differs from the traditional atherosclerotic model. Although ordinary risk factors such as age, gender, diabetes, hypertension, and smoking still apply, others such as left ventricular hypertrophy and uraemic cardiomyopathy are relevant. Transplantation also adds specific risks such as immunosuppressive therapies and acute rejection. Understanding and managing the cardiovascular risk in this population is limited by a lack of large-scale randomized trials. The approach to managing the cardiovascular risk profile of these patients should be multifactorial and start even before transplantation.
APA, Harvard, Vancouver, ISO, and other styles
40

Johnston, Derek W. Cardiovascular disease. Oxford University Press, 2015. http://dx.doi.org/10.1093/med:psych/9780192627254.003.0014.

Full text
Abstract:
Chapter 14 explores the role of behavioural medicine in the treatment of cardiovascular disease. It discusses stress management in the treatment of primary hypertension, coronary heart disease, and angina pectoris, along with rehabilitation, and future developments for research and treatment.
APA, Harvard, Vancouver, ISO, and other styles
41

Telford, Richard, and Peter Murphy. Cardiovascular disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198719410.003.0003.

Full text
Abstract:
This chapter describes the anaesthetic management of the patient with cardiovascular disease. The topics include ischaemic heart disease (including perioperative myocardial infarction and percutaneous coronary intervention), valvular heart disease (including prosthetic valves), congenital heart disease, cardiomyopathy, pericardial disease, and the patient with a transplanted heart. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.
APA, Harvard, Vancouver, ISO, and other styles
42

Telford, Richard, and Peter Murphy. Cardiovascular disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198719410.003.0003_update_001.

Full text
Abstract:
This chapter describes the anaesthetic management of the patient with cardiovascular disease. The topics include ischaemic heart disease (including perioperative myocardial infarction and percutaneous coronary intervention), valvular heart disease (including prosthetic valves), congenital heart disease, cardiomyopathy, pericardial disease, and the patient with a transplanted heart. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described.
APA, Harvard, Vancouver, ISO, and other styles
43

Caroline, Mara, Ryan Bradley, and Mimi Guarneri. Cardiovascular Disease. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190466268.003.0013.

Full text
Abstract:
The older population is challenging to treat for numerous reasons, including comorbid conditions and increased susceptibility to adverse drug reactions, limiting medical therapy. They are at increased risk for loneliness and depression, which strongly impacts their cardiovascular outcomes, and they also have different values, usually prioritizing quality of life over mortality objectives. Finally, the elderly are underrepresented in cardiovascular clinical trials, thus limiting the applicability of guideline recommendations. This chapter emphasizes the importance of a comprehensive assessment of individual circumstances when assessing cardiovascular health in the elderly population. The chapter focuses on the role of nutrition, resiliency, and exercise for the prevention and treatment of cardiovascular disease. Nutrient deficiencies commonly seen with cardiovascular drugs are also discussed, as well as specific integrative strategies for optimizing dyslipidemia, atrial fibrillation, and heart failure in this population.
APA, Harvard, Vancouver, ISO, and other styles
44

Wohl, David A., and Jeffrey T. Kirchner. Cardiovascular Disease. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0041.

Full text
Abstract:
There is a growing body of evidence that HIV-infected persons are at increased risk for cardiovascular disease (CVD) and associated complications, including myocardial infarction and stroke. Autopsy studies have noted premature atherosclerosis in HIV-infected adults, and epidemiological studies demonstrate higher rates of CVD among HIV-infected compared to HIV-uninfected patients. These findings are in part due to chronic inflammation and immune activation associated with HIV infection. Traditional CVD risk factors, including hypertension, hyperlipidemia, and cigarette smoking, also play keys roles. There is additional evidence from observational cohort studies that some antiretroviral drugs, including protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of myocardial infarction. Treatment interventions to reduce the risk of CVD include diet, exercise, smoking cessation, lipid-lowering agents, and antihypertensive medications. For select patients, changing antiretroviral therapy to improve lipid profiles may be appropriate but should not compromise virologic or immunologic control.
APA, Harvard, Vancouver, ISO, and other styles
45

Cardiovascular Disease. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

Cardiovascular Disease. MDPI, 2021. http://dx.doi.org/10.3390/books978-3-0365-0993-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Hatfield, Anthea. Cardiovascular disease. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199666041.003.0018.

Full text
Abstract:
Cardiovascular disease is common and patients coming to recovery room with any of these common problems will need special care. The essential signs and symptoms of hypertension, cardiac failure, ischaemic heart disease, and valvular heart disease are outlined. The actions and side-effects of the drugs that these patients take to control their symptoms are described. Recognizing and treating hypotension and myocardial ischaemia are very important and relevant, and they are fully discussed in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
48

Frayn, Keith, and Sara Stanner, eds. Cardiovascular Disease. Wiley, 2005. http://dx.doi.org/10.1002/9780470774663.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Stanner, Sara, Sarah Coe, and Keith N. Frayn, eds. Cardiovascular Disease. Wiley, 2018. http://dx.doi.org/10.1002/9781118829875.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Lorimer, A. R., and William Stewart Williams. Cardiovascular Disease. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography